Evercore ISI has reduced its price target for MetLife (NYSE:MET) stock to $95 from $97, while maintaining an “In Line” rating. This adjustment follows MetLife’s Q4 2025 results and 2026 outlook, although Evercore ISI kept its 2026 and 2027 EPS estimates unchanged, noting that the price target change primarily reflects an “uneconomic” accounting modification related to real estate. Despite the reduced target, the new price still suggests a potential 22% upside from the current price.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
MetLife price target lowered to $95 from $97 at Evercore ISI
Evercore ISI has reduced its price target for MetLife (NYSE:MET) stock to $95 from $97, while maintaining an “In Line” rating. This adjustment follows MetLife’s Q4 2025 results and 2026 outlook, although Evercore ISI kept its 2026 and 2027 EPS estimates unchanged, noting that the price target change primarily reflects an “uneconomic” accounting modification related to real estate. Despite the reduced target, the new price still suggests a potential 22% upside from the current price.